Nina E. Glass

Nina E. Glass

Auto-generated profile, based on publicly available information

Nina E. Glass

Department of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2024 in Global Spine Journal
Verified
Journal Article
Open access
BKBrian K Kwon
Brian K Kwon
LTLindsay A. Tetreault
Lindsay A. Tetreault
AMAllan R. Martin
Allan R. Martin
PAPaul M Arnold
Paul M Arnold
RMRex A.W. Marco
Rex A.W. Marco
Michael FehlingsMichael Fehlings
Michael Fehlings
Study Design: Clinical practice guideline development following the GRADE process. Objectives: Hemodynamic management is one of the only available treatment options that likely improves neurologic outcomes in patients with acute traumatic spinal cord injury (SCI). Augmenting mean arterial pressure (MAP) aims to improve blood perfusion and oxygen delivery to the injured spinal cord in order to minimize secondary ischemic damage to neural tissue. The objective of this guideline was to update the 2013 AANS/CNS recommendations on the hemodynamic management of patients with acute traumatic SCI, acknowledging that much has been published in this area since its publication. Specifically, we sought to make recommendations on 1. The range of mean arterial pressure (MAP) to be maintained by identifying an upper and lower MAP limit; 2. The duration of such MAP augmentation; and 3. The choice of vasopressor. Additionally, we sought to make a recommendation on spinal cord perfusion pressure (SCPP) targets. Methods: A multidisciplinary guideline development group (GDG) was formed that included health care professionals from a wide range of clinical specialities, patient advocates, and individuals living with SCI. The GDG reviewed the 2013 AANS/CNS guidelines and voted on whether each recommendation should be endorsed or updated. A systematic review of the literature, following PRISMA standards and registered in PROSPERO, was conducted to inform the guideline development process and address the following key questions: (i) what are the effects of goal-directed interventions to optimize spinal cord perfusion on extent of neurological recovery and rates of adverse events at any time point of follow-up? and (ii) what are the effects of particular monitoring techniques, perfusion ranges, pharmacological agents, and durations of treatment on extent of neurological recovery and rates of adverse events at any time point of follow-up? The GDG combined the information from this systematic review with their clinical expertise in order to develop recommendations on a MAP target range (specifically an upper and lower limit to target), the optimal duration for MAP augmentation, and the use of vasopressors or inotropes. Using methods outlined by the GRADE working group, recommendations were formulated that considered the balance of benefits and harms, financial impact, acceptability, feasibility and patient preferences. Results: The GDG suggested that MAP should be augmented to at least 75-80 mmHg as the “lower limit,” but not actively augmented beyond an “upper limit” of 90-95 mmHg in order to optimize spinal cord perfusion in acute traumatic SCI. The quality of the evidence around the “target MAP” was very low, and thus the strength of this recommendation is weak. For duration of hemodynamic management, the GDG “suggested” that MAP be augmented for a duration of 3-7 days. Again, the quality of the evidence around the duration of MAP support was very low, and thus the strength of this recommendation is also weak. The GDG felt that a recommendation on the choice of vasopressor or the use of SCPP targets was not warranted, given the dearth of available evidence. Conclusion: We provide new recommendations for blood pressure management after acute SCI that acknowledge the limitations of the current evidence on the relationship between MAP and neurologic recovery. It was felt that the low quality of existing evidence and uncertainty around the relationship between MAP and neurologic recovery justified a greater range of MAP to target, and for a broader range of days post-injury than recommended in previous guidelines. While important knowledge gaps still remain regarding hemodynamic management, these recommendations represent current perspectives on the role of MAP augmentation for acute SCI.

20 April 2012 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
CTCaroline C. Tigoi
Caroline C. Tigoi
HGHellen Gatakaa
Hellen Gatakaa
AKAngela Karani
Angela Karani
DMDaisy Mugo
Daisy Mugo
SKStella Kungu
Stella Kungu
JSJ. Anthony G. Scott
J. Anthony G. Scott
Background. Herd protection and serotype replacement disease following introduction of pneumococcal conjugate vaccine (PCV) are attributable to the vaccine's impact on colonization. Prior to vaccine introduction in Kenya, we did an epidemiological study to estimate the rate of pneumococcal acquisition, by serotype, in an uncolonized population. Methods. Nasopharyngeal swab specimens were taken from newborns aged ≤7 days and weekly thereafter for 13 weeks. Parents, and siblings aged <10 years, were swabbed at monthly intervals. Swabs were transported in skim milk-tryptone-glucose-glycerin and cultured on gentamicin blood agar. Pneumococci were serotyped by the Quellung reaction. We used survival analysis and Cox regression analysis to examine serotype-specific acquisition rates and risk factors and calculated transmission probabilities from the pattern of acquisitions within the family. Results. Of 1404 infants recruited, 887 were colonized by 3 months of age, with the earliest acquisition detected on the first day of life. The median time to acquisition was 38.5 days. The pneumococcal acquisition rate was 0.0189 acquisitions/day (95% confidence interval, .0177–.0202 acquisitions/day). Serotype-specific acquisition rates varied from 0.00002–0.0025 acquisitions/day among 49 different serotypes. Season, coryza, and exposure to cigarettes, cooking fumes, and other children in the home were each significant risk factors for acquisition. The transmission probability per 30-day duration of contact with a carrier was 0.23 (95% CI, .20–.26). Conclusions. Newborn infants in Kilifi have high rates of nasopharyngeal acquisition of pneumococci. Half of these acquisitions involve serotypes not included in any current vaccine. Several risk factors are modifiable through intervention. Newborns represent a consistent population of pneumococcus-naive individuals in which to estimate the impact of PCV on transmission.

15 February 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SMSusan B. Manoff
Susan B. Manoff
CLCharles Liss
Charles Liss
MCMichael J. Caulfield
Michael J. Caulfield
RMRocio D. Marchese
Rocio D. Marchese
JSJeffrey Silber
Jeffrey Silber
GCGeorge M. Carlone
George M. Carlone
Background. Older adults are at high risk of developing invasive pneumococcal disease, but the optimal timing and number of vaccine doses needed to p

1 January 2015 in The American Journal of Surgery
Verified
Journal Article
Closed access
NGNina E. Glass
Nina E. Glass
AKAfif N. Kulaylat
Afif N. Kulaylat
FZFeibi Zheng
Feibi Zheng
CGCarly E. Glarner
Carly E. Glarner
KEKonstantinos Economopoulos
Konstantinos Economopoulos
RWRobert D. Winfield
Robert D. Winfield

1 January 2020 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
MSMargaret L. Schwarze
Margaret L. Schwarze
ABAnne Buffington
Anne Buffington
JTJennifer L. Tucholka
Jennifer L. Tucholka
BHBret Hanlon
Bret Hanlon
PRPaul J. Rathouz
Paul J. Rathouz
KBKaren J. Brasel
Karen J. Brasel
Each year, more than 500 000 older Americans have major surgery to treat a serious oncologic or vascular problem.1,2 Although surgery can prolong life and reduce symptoms, there are significant trade-offs associated with major surgery in patients 65 years and older; older patients are more likely to require intensive care, have lengthy hospitalizations, or transfer to extended care facilities after surgery.3,4 Therefore, decisions to proceed with surgery can start patients along a care trajectory inconsistent with their personal preferences and overall health goals. Moreover, even patients who avoid complications can feel blindsided when the expected outcomes of surgery are overwhelming5,6 or they fail to return to normal. Poor preoperative communication can have serious consequences, including unwanted treatment7,8 and conflict between surgeons and patients about postoperative care.9-11

1 February 2020 in Journal of Surgical Research
Verified
Journal Article
Closed access
FHFranchesca Hwang
Franchesca Hwang
SPSri Ram Pentakota
Sri Ram Pentakota
NGNina E. Glass
Nina E. Glass
ABAna Berlin
Ana Berlin
DLDavid H. Livingston
David H. Livingston
AMAnne C. Mosenthal
Anne C. Mosenthal